Τετάρτη 16 Σεπτεμβρίου 2026
5 άρθρα
EPA scraps most power-plant carbon limits
The final repeal removes US emission limits on existing coal plants and new gas turbines, with EPA projecting 123 million extra tonnes of CO₂ annually by 2035. It may deepen Europe’s industrial cost disadvantage, but no measurable impact is evident yet—and the agency has not reconciled its claimed $300 billion saving with an earlier $19 billion estimate.
France’s 2027 spending freeze lacks figures
Lecornu has ordered ministries to keep spending flat in cash terms, exempting defence, as France confronts a projected 5.7% deficit and rising borrowing costs. Yet no spending baseline or ministry allocations have been published, leaving Parliament without a costed plan and the government’s roughly €30 billion fiscal package largely composed of options rather than decisions.
France’s bond premium nears 100 basis points
European yields are climbing as inflation, $108 oil and an ECB rate increase reset borrowing costs across the eurozone. France faces an added penalty: investors are demanding roughly one percentage point more than from Germany, reflecting doubts that its divided National Assembly can pass the 2027 budget.
Europe’s plant-glow satellite faces its test
FLEX has reached orbit with an instrument built to detect the faint fluorescence plants emit during photosynthesis, potentially revealing stress before leaves visibly deteriorate. The satellite must now complete three months of calibration and validation before scientists know whether it can reliably map that signal across 150-kilometre swaths at 300-metre resolution.
Two Breast-Cancer Drugs, Two Treatment Clocks
Camizestrant allows doctors to switch therapy when a blood test detects resistance, months before scans show the cancer worsening. Vepdegestrant is used only after progression and remains unapproved in Europe, while camizestrant’s rollout depends on reimbursement, repeated molecular testing and eventual proof that earlier intervention extends life.